Semaglutide and similar GLP-1 medications — including medications such as Ozempic, Wegovy, Mounjaro, and Zepbound — are being studied for their possible effects on alcohol cravings and addiction. Early findings are promising, but these medications are not currently standard or FDA-approved treatments for alcohol use disorder.
Proven treatments such as naltrexone, Vivitrol, acamprosate, disulfiram, counseling, and individualized medical care remain the foundation of treatment.
